marijuana stocks news

Cara Therapeutics to Webcast Presentation at 23rd Annual NewsMakers in the Biotech Industry Conference

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 23rd Annual NewsMakers in the Biotech Industry Conference on Friday, September 9, 2016, at 10:30 a.m. ET in New York.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website atwww.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$AXXU Hires a VP of Channel Partners and Alliances

Encompass Compliance Corporation (AXXU) Hires a VP of Channel Partners and Alliances…

Innovative Industrial Properties, Inc. (IIPR) Acquires Property in Florida and Enters Into Long-Term Lease with Harvest

Innovative Industrial Properties Acquires Property in Florida and Enters Into Long-Term Lease…

 InMed Pharmaceuticals Inc. (IMLFF) to Report Third Quarter Fiscal 2020 Financial Results

InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business…

$AFI Signs Licensing Agreement With a Private Farm in Tennessee

Affinor Growers Signs Licensing Agreement With a Private Farm in Tennessee Affinor…